However, even with 4–6 mice, lung tumorigenesis was dramatically reduced as evidenced by significantly fewer tumor nodules and markedly smaller tumors in COX-2 null K-ras mice compared to that in K-ras mice, suggesting that the COX-2 pathway is important for KRAS mutation induced lung tumorigenesis. The gene discussed is PTGS2; the disease is neoplasm.